As of November 30, 2025, HC Surgical Specialists Ltd carries a market capitalization of 52.15M, placing it among publicly traded companies globally. Its enterprise value stands at 47.60M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 52.15M |
| Enterprise Value | 47.60M |
As of November 30, 2025, HC Surgical Specialists Ltd has 153.38M shares outstanding.
| Shares Outstanding | 153.38M |
These figures are as of November 30, 2025.
| PB Ratio | 2.26 |
| P/TBV Ratio | 2.64 |
As of November 30, 2025, HC Surgical Specialists Ltd maintains a current ratio of 1.96, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.96 |
| Quick Ratio | 1.38 |
| Debt / Equity | 10.53 |
These figures cover the twelve months ended November 30, 2025.
| Employee Count | 18.00 |
As of the close on October 20, 2026, HC Surgical Specialists Ltd's stock has gained approximately 2.86% over the past 52 weeks. The 50-day moving average sits at 0.36, while the 200-day moving average is 0.36.
| 52-Week Price Change | 2.86% |
| 50-Day Moving Average | 0.36 |
| 200-Day Moving Average | 0.36 |
As of November 30, 2025, HC Surgical Specialists Ltd holds 6.63M in cash and equivalents against 2.40M in total debt, resulting in a net debt position of -5.98M. Total book value stands at 23.11M, with working capital of 4.58M providing operational flexibility.
| Cash & Cash Equivalents | 6.63M |
| Total Debt | 2.40M |
| Net Debt | -5.98M |
| Equity (Book Value) | 23.11M |
| Book Value Per Share | 0.15 |
| Working Capital | 4.58M |
Already premium?